hVIVO PLC (HVO)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

7.20p

Buy

7.50p

arrow-up0.35p (+5.00%)

Prices updated at 19 Dec 2025, 16:28 GMT

Prices minimum 15 mins delay

Prices in GBX

Venn Life Sciences Holdings PLC is engaged into a Clinical Research Organisation (CRO) providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

FTSE All-Share

0.53%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	56m	63m
	-	-
	10m	13m
	18.42	20.50
	16m	11m
	14m	18m
Sales, General and administrative	24m	26m
Interest expenses	155,000	955,000
Provision for income taxes	-5m	3m
Operating expenses	46m	50m
Income before taxes	11m	13m
Net income available to common shareholders	16m	11m
	0.0238	0.0157
Net interest income	1m	721,000
Advertising and promotion	-	-
Net investment income, net	50,000	-259,000
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.0235	0.0155
Free cash flow per share	0.0288	0.0095
Book value/share	0.0318	0.0565
Debt equity ratio	0.354338	0.232591

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	52m	60m
Current liabilities	35m	32m
Total capital	34m	45m
Total debt	13m	13m
Total equity	34m	45m
Total non current liabilities	-	-
Loans	-	-
Total assets	83m	89m
Total liabilities	-	-
Cash and cash equivalents	37m	44m
Common stock	680m	680m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	28m	37m
Cash dividends paid	-3m	-1m
	12m	8m
Investments (gains) losses	-5m	-660,000
	37m	44m
Net income	-	-
	17m	10m
	-5m	-2m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.